21-hydroxylase deficiency: Difference between revisions
Jump to navigation
Jump to search
m (Mehdi Pahlavani moved page Congenital adrenal hyperplasia due to 21-hydroxylase deficiency to 21-hydroxylase deficiency without leaving a redirect) |
Gerald Chi- (talk | contribs) m (Reverted edits by Gerald Chi- (talk) to last revision by Aditya Ganti) Tag: Rollback |
||
| (13 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{ | {{21-hydroxylase deficiency}} | ||
{{CMG}} {{MJ}} | {{CMG}}; {{AE}} {{MJ}} {{AAM}} | ||
{{SK}} Congenital adrenal hyperplasia due to | {{SK}} Congenital adrenal hyperplasia due to 21-hydroxylase deficiency; 21-hydroxylase deficient congenital adrenal hyperplasia; CAH1; CYP21A deficiency; Congenital adrenal hyperplasia 1 | ||
==[[ | ==[[21-hydroxylase deficiency overview|Overview]]== | ||
==[[ | ==[[21-hydroxylase deficiency historical perspective|Historical Perspective]]== | ||
==[[ | ==[[21-hydroxylase deficiency classification|Classification]]== | ||
==[[ | ==[[21-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[21-hydroxylase deficiency causes|Causes]]== | ||
==[[ | ==[[21-hydroxylase deficiency differential diagnosis|Differentiating 21-hydroxylase deficiency from other Diseases]]== | ||
==[[ | ==[[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[21-hydroxylase deficiency risk factors|Risk Factors]]== | ||
==[[ | ==[[21-hydroxylase deficiency screening|Screening]]== | ||
==[[ | ==[[21-hydroxylase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[21-hydroxylase deficiency history and symptoms| History and Symptoms]] | [[21-hydroxylase deficiency physical examination | Physical Examination]] | [[21-hydroxylase deficiency laboratory findings|Laboratory Findings]] | [[21-hydroxylase deficiency electrocardiogram|Electrocardiogram]] | [[21-hydroxylase deficiency CT|CT]] | [[21-hydroxylase deficiency MRI|MRI]] | [[21-hydroxylase deficiency ultrasound|Ultrasound]] | [[21-hydroxylase deficiency other imaging findings|Other Imaging Findings]] | [[21-hydroxylase deficiency other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[21-hydroxylase deficiency medical therapy|Medical Therapy]] | [[21-hydroxylase deficiency surgery|Surgery]] | [[21-hydroxylase deficiency primary prevention|Primary Prevention]] | [[21-hydroxylase deficiency secondary prevention|Secondary Prevention]] | [[21-hydroxylase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[21-hydroxylase deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[ | [[21-hydroxylase deficiency case study one|Case#1]] | ||
==Related Chapters== | ==Related Chapters== | ||
| Line 47: | Line 48: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Intersexuality]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 21:08, 25 July 2020
For patient information click here
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2] Ahmad Al Maradni, M.D. [3]
Synonyms and keywords: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency; 21-hydroxylase deficient congenital adrenal hyperplasia; CAH1; CYP21A deficiency; Congenital adrenal hyperplasia 1
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 21-hydroxylase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters